| Leishmanization | Live and virulent L. major or L. tropica |
| Killed vaccines | Killed Leishmania species |
| Live genetically modified vaccines (avirulent) | BT1 (biopterin transporter 1) |
| Ldp27 (L. donovani amastigote specific protein p27) |
| HSP70-II nul (heat-schok protein) |
| KHARON1 |
| Cen (centrin) |
| Recombinant and subunit vaccines | Recombinant LEISH-F1, LIESH-F2 and LEISH-F3 |
| LdA2, Ldp27, eIF-2, NH (nucleoside hydrolase), CPA (cysteine protease A), CPB, SMT (sterol 24-c-methyltransferase), H1 (histone-1), HSP, LACK |
| Sand fly saliva antigens: LJM19, LJL143, and PdSP15 |
| DNA vaccines | A2, LACK, TSA + LmSTI1, gp63 (glycoprotein 63), KMP-11 (kinetoplastid membrane protein 11), CPB, NH36, LeIF, gp63 + HS |
| Semian adenovirus expressing NH and SMT |
| Live non-pathogenic vaccines | Avirulent Leishmania tarentolae |